We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Most Closely HLA Matched Allogeneic Virus Specific Cytotoxic T-Lymphocytes (CTL) (CHALLAH)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00711035
First Posted: July 8, 2008
Last Update Posted: April 26, 2016
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
Texas Children's Hospital
The Methodist Hospital System
Brigham and Women's Hospital
Massachusetts General Hospital
M.D. Anderson Cancer Center
National Marrow Donor Program
The EMMES Corporation
Duke University
Beth Israel Deaconess Medical Center
Children's Hospital Los Angeles
National Heart, Lung, and Blood Institute (NHLBI)
Boston Children’s Hospital
University of Miami
Hackensack University Medical Center
University of California, Los Angeles
Information provided by (Responsible Party):
Helen Heslop, Baylor College of Medicine
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2013
  Primary Completion Date: October 2012 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Submission: March 3, 2014
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):